• Subscribe
  • Newsfeed
  • About
Announce News

Allos AI

To add a bio or update company history, please click update information.

News from Allos AI

    Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugsAllos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugsAllos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
    13 Jan 2026

    Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

    Allos AI applies causal AI to reformulate complex generic drugs, improving delivery, tolerability and predictability while reducing development uncertainty.

Allos AI
  • Life Sciences
  • Oxford, United Kingdom
  • £4m
  • allos.ai
  • Update Information

More venture news

  • Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable
    Outpost Bio
    2 Mar 2026

    Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable

    Pre-seedLife Sciences
  • Sonas Pharma secures pre-seed funding led by SFC Capital to develop therapeutics for obesity and epilepsy
    Sonas Pharma
    25 Feb 2026

    Sonas Pharma secures pre-seed funding led by SFC Capital to develop therapeutics for obesity and epilepsy

    Pre-seedLife Sciences
  • Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
    Allos AI
    13 Jan 2026

    Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn